Victory Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.3K | Buy |
28,330
+4,305
| +18% | +$2.33K | ﹤0.01% | 2458 |
|
|
2025
Q1 | $15.8K | Sell |
24,025
-602
| -2% | -$395 | ﹤0.01% | 2442 |
|
|
2024
Q4 | $25.1K | Buy |
24,627
+848
| +4% | +$865 | ﹤0.01% | 2432 |
|
|
2024
Q3 | $20.6K | Sell |
23,779
-321
| -1% | -$278 | ﹤0.01% | 2442 |
|
|
2024
Q2 | $8.64K | Buy |
+24,100
| New | +$8.64K | ﹤0.01% | 2471 |
|
|
2023
Q4 | – | Sell |
-16,738
| Closed | -$10K | – | 2633 |
|
|
2023
Q3 | $10K | Buy |
16,738
+747
| +5% | +$448 | ﹤0.01% | 2486 |
|
|
2023
Q2 | $20.8K | Buy |
15,991
+1,266
| +9% | +$1.65K | ﹤0.01% | 2446 |
|
|
2023
Q1 | $25.9K | Sell |
14,725
-200
| -1% | -$352 | ﹤0.01% | 2493 |
|
|
2022
Q4 | $46.9K | Sell |
14,925
-6
| -0% | -$19 | ﹤0.01% | 2460 |
|
|
2022
Q3 | $73K | Sell |
14,931
-937
| -6% | -$4.58K | ﹤0.01% | 2521 |
|
|
2022
Q2 | $66K | Sell |
15,868
-29
| -0.2% | -$121 | ﹤0.01% | 2520 |
|
|
2022
Q1 | $66K | Sell |
15,897
-421
| -3% | -$1.75K | ﹤0.01% | 2568 |
|
|
2021
Q4 | $122K | Sell |
16,318
-687
| -4% | -$5.14K | ﹤0.01% | 2546 |
|
|
2021
Q3 | $153K | Sell |
17,005
-452
| -3% | -$4.07K | ﹤0.01% | 2572 |
|
|
2021
Q2 | $209K | Sell |
17,457
-464
| -3% | -$5.56K | ﹤0.01% | 2519 |
|
|
2021
Q1 | $225K | Sell |
17,921
-324
| -2% | -$4.07K | ﹤0.01% | 2500 |
|
|
2020
Q4 | $285K | Buy |
18,245
+1,211
| +7% | +$18.9K | ﹤0.01% | 2295 |
|
|
2020
Q3 | $161K | Sell |
17,034
-1,205
| -7% | -$11.4K | ﹤0.01% | 2309 |
|
|
2020
Q2 | $163K | Sell |
18,239
-19,143
| -51% | -$171K | ﹤0.01% | 2326 |
|
|
2020
Q1 | $238K | Buy |
37,382
+14,778
| +65% | +$94.1K | ﹤0.01% | 2289 |
|
|
2019
Q4 | $189K | Buy |
22,604
+3,078
| +16% | +$25.7K | ﹤0.01% | 2324 |
|
|
2019
Q3 | $177K | Buy |
+19,526
| New | +$177K | ﹤0.01% | 2256 |
|